Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis

A recent review that addressed, through meta-analysis of pusblished data, the safety and efficacy of autologous
mesenchymal stem cells (aMSCs) in treating MS patients.

Source: Hindawi, Stem Cells International

Leave a reply